Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPN171H for erectile dysfunction
CTR20213450Phase 3Completed
- Sponsor
- Shanghai Institute of Materia Medica
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in erectile dysfunction (ED) comparing TPN171H with Placebo (2 arms). Primary endpoints: Change from baseline in IIEF-EF domain score at week 12, Change in percentage of successful penetration attempts (SEP2) over 12 weeks and 1 more. Started Dec 2021; status: completed.
02
Drugs
TPN171H
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on CTR20213450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20213450.